logo
calendar3 Yanvar 2020
view27
Main language:Russian

CONDITION OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH ACROMEGALY

Field of Science:
pdf

file.pdf

PDF

Биомедицина ва амалиёт журнали

Биомедицина ва амалиёт журнали

Publish Articlesee more

ARTICLE ANNOTATION

quote
We examined 60 patients aged 20 to 62 years who underwent transnasal adenomectomy. In addition to the latter, 17 patients received stereotactic, 12 - traditional hyperfractionated radiation therapy All patients after surgery and radiation therapy received an analog of somatostatin (Somatullin Autozhel, Ipsen). In all patients, blood pressure was determined, body mass index was calculated, basal GH and insulin-like growth factor 1 were determined, electrocardiogram and echocardiogram were performed. The state of carbohydrate metabolism was determined: determination of fasting glycemia and the level of HvA1c. The diagnosis of acromegaly, its activity and severity were established taking into account the clinical picture, the results of hormonal and instrumental examination in accordance with modern clinical and laboratory criteria.

AUTHORS

R.Bazarbekova

Қозоғистон тиббиий узулуксиз таълим университети

A.Dosanova

Қозоғистон тиббиий узулуксиз таълим университети

M.Qazaqova

Қозоғистон тиббиий узулуксиз таълим университети

Tags

# Акромегалия# нейроэндокринное заболевание# соматотропин# сердечно-сосудистая и респиратор# кардиомиоциты# сердечной мышца# нейроэндокрин касаллик# ўсиш гормони# юрак-қон томир ва нафас олиш пат# кардиомиоцитлар# Acromegaly# neuroendocrine disease# growth hormone# cardiovascular and respiratory p# cardio myocytes# cardiac muscle.# юрак мушаклари.

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0037/A0120-0007

DOI:

Not Available

References

1. Gesmundo I, Miragoli M, Carullo P. et all. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure // Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12033-12038. doi: 10.1073/pnas.1712612114. Epub 2017 Oct 25.

2. Shlomo Melmed, Marcello D. Bronstein, Philippe Chanson et all,A Consensus Statement on acromegaly therapeutic outcomes // Nature Reviews Endocrinology 14, pages 552–561 (2018).

3. Lang R., Bierig M., Devereux R. et al. Рекомендации по количественной оценке структуры и функции камер сердца // Рос. кардиол. журн. – 2012; 3: 28.

4. Colao A1 , Grasso LFS2 , Di Somma C3 , Pivonello R Acromegaly and Heart Failure // Heart Fail Clin. 2019 Jul;15(3):399-408. doi: 10.1016/j.hfc.2019.03.001.

5. Bogazzi F., Russo D, Raggi F Cardiac extrinsic apoptotic pathway is silent in young but activated in elder mice overexpressing bovine GH: interplay with the intrinsic pathway // J Endocrinol. 2011 Aug;210(2):231-8. doi: 10.1530/JOE-10-0402. Epub 2011 May 12.

6. Anciferov M.B., Alekseeva T.M., Pronin V.S. Moskovskij Registr bol›nyh akromegaliej: otdalennye rezul›taty nablyudeniya // Sovremennye aspekty farmakoterapii endokrinnyh zabolevanij pod red. Anciferova M.B. Sbornik izbrannyh nauchno-metodicheskih statej zhurnala \[ Moscow Register of Acromegaly Patients: Long-Term Surveillance Results // Modern Aspects of Pharmacotherapy of Endocrine Diseases, ed. Antsiferova M.B. A collection of selected scientific and methodological articles of the journal] “Farmateka\”-M., 2017, - str.167-172.

7. Kovaleva Yu.A., Ilovajskaya I.A., Dreval’ A.V., Starostina E.G. Kardiorespiratornye narusheniya pri akromegalii [Cardiorespiratory disorders in acromegaly] // RMZh. 2016. No 1. S. 19–24.

8. Kosareva O., Sharonova L., Verbovoj A. Funkcional’noe sostoyanie miokarda i uroven’ natrijureticheskih propeptidov pri akromegalii na raznyh stadiyah zabolevaniya // Vrach. -№4. - 2013.- S. 78- 81.

9. Egorova N.A., Halimov Yu.Sh., Nikiforov V.S. i dr.Vzaimosvyaz’ pokazatelej sutochnogo monitorirovaniya arterial’nogo davleniya i gormonal’noj aktivnosti so strukturno-funkcional’nymi harakteristikami miokarda u bol’nyh akromegaliej v zavisimosti ot nalichiya arterial’noj gipertenzii [Interrelation of indicators of daily monitoring of blood pressure and hormonal activity with structural and functional characteristics of the myocardium in patients with acromegaly, depending on the presence of arterial hypertension] // Arterial’naya gipertoniya - T. 17, № 2 - 2011.

10. Abramenko A.S., Vishnyakova M.V., Vishnyakova M.V., Dreval’ A.V., Kovaleva Yu.A. Magnitnorezonansnaya tomografiya v diagnostike porazhenij serdca u bol’nyh akromegaliej [Magnetic resonance imaging in the diagnosis of heart lesions in patients with acromegaly] // Al’manah klinicheskoj mediciny. 2015;(43):19-26. https://doi.org/10.18786/2072-0505-2015-43-19-26.

11. Zhulidova A.Yu., Dubinina I.I. Akromegaliya i komorbidnye sostoyaniya. Novye vozmozhnosti diagnostiki i lecheniya (obzor literatury) [Acromegaly and comorbid conditions. New diagnostic and treatment options (literature review) ] // Rossiskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova. 2018. T. 26. №1. S. 117-132. DOI: 10.23888/PAVLOVJ2018261117-132

12. Belaya Zh.E., Rozhinskaya L.Ya., Dragunova N.V., Dzeranova L.K., Marova E.I., Arapova S.D., i dr. Metabolicheskie oslozhneniya endogennogo giperkorticizma. Vybor pacientov dlya skrininga [Metabolic complications of endogenous hypercorticism. Selection of patients for screening.]. // Ozhirenie i Metabolizm. - 2013. - №1. - S. 26-31. doi: 10.14341/2071-8713-5068

13. Ekhokardiografiya: mezhdunarodnye prakticheskie rukovodstva i rekomendacii.[ Echocardiography: international practical guidelines and recommendations] / A.Zh. Arystan, D.V. Fetcer, D.A. Osmonov, V.V. Benberin. Pod redakciej T.A. Batyralieva. – Bishkek: OsOO «Global Print», 2018 – 120 s.